Your browser doesn't support javascript.
loading
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study.
Bastin, Marie; Allouchery, Marion; Sassier, Marion; Rouby, Franck; Eftekhari, Pirayeh; Lebrun-Vignes, Bénédicte; Andreelli, Fabrizio; Bihan, Kevin.
Afiliação
  • Bastin M; Pitié Salpêtrière Hospital, Diabetology Dpt, Sorbonne University, APHP, 75013 Paris, France.
  • Allouchery M; Regional Pharmacovigilance Center, Department of clinical Pharmacology, University of Poitiers, Poitiers University Hospital, 86073 Poitiers, France.
  • Sassier M; Regional Pharmacovigilance Center, Department of Pharmacology, Caen University Hospital, 14000 Caen, France.
  • Rouby F; Regional Pharmacovigilance Center, Department of Pharmacology, Aix-Marseille University Hospital, 13015 Marseille, France.
  • Eftekhari P; Regional Pharmacovigilance Center, Department of Pharmacology, Fernand-Widal Hospital, 75010 Paris, France.
  • Lebrun-Vignes B; Regional Pharmacovigilance Center, Department of Pharmacology, Pitié-Salpêtrière Hospital, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
  • Andreelli F; Pitié Salpêtrière Hospital, Diabetology Dpt, Sorbonne University, APHP, 75013 Paris, France.
  • Bihan K; Regional Pharmacovigilance Center, Department of Pharmacology, Pitié-Salpêtrière Hospital, 47-83, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: kevin.bihan@aphp.fr.
Therapie ; 76(6): 695-703, 2021.
Article em En | MEDLINE | ID: mdl-33836905
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article